Home World News Sacituzumab tirumotecan shows significant clinical benefit in advanced/recurrent endometrial cancer World News Sacituzumab tirumotecan shows significant clinical benefit in advanced/recurrent endometrial cancer By Ogkologos - October 26, 2026 9 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR Can ctDNA guide treatment intensification in EGFR mutated non-small cell lung cancer? How to select adjuvant endocrine therapy for postmenopausal women with HR-positive early breast cancer? EMA Recommends Extension of Therapeutic Indications for Abiraterone Acetate MOST POPULAR Lung-Sparing Surgery Is Effective for Some with Early-Stage Lung Cancer March 9, 2023 Artist Tattoos Realistic Nipples On Breast Cancer Survivors Post-Mastectomy October 13, 2021 Women with Diabetes Less Likely to Opt into Cancer Screening, Despite... October 25, 2019 The UK Government’s spending review: Time to invest in the future... October 20, 2020 Load more HOT NEWS Coronavirus Vaccines and People with Cancer: A Q&A with Dr. Steven... New tool to tackle gaps in public’s knowledge of blood cancer... FDA Grants Accelerated Approval to Repotrectinib for Adult and Paediatric Patients... FDA Approves Combination of Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf for HER2-positive Breast...
